Query Result Set
Skip Navigation Links
   ActiveUsers:371Hits:19889194Skip Navigation Links
Show My Basket
Contact Us
IDSA Web Site
Ask Us
Today's News
HelpExpand Help
Advanced search

  Hide Options
Sort Order Items / Page
PROTECTIVE ANTIGEN (1) answer(s).
 
SrlItem
1
ID:   149011


Humoral immune response to various domains of protective antigen of bacillus anthracis in cutaneous anthrax cases in india / Anshul Varshney, ; Goel, A K; Kumar, M ; Puranik, Nidhi   Journal Article
Anshul Varshney, Nidhi Puranik, M. Kumar, A.K. Goel Journal Article
0 Rating(s) & 0 Review(s)
Summary/Abstract Anthrax, caused by Bacillus anthracis is known to occur globally since antiquity. Besides being an important biothreat agent, it is an important public health importance pathogen also in countries like India. B. anthracis secretes three distinct toxins, namely protective antigen (PA), lethal factor (LF) and edema factor (EF). PA is the central moiety of the anthrax toxin complex and therefore has been a molecule of choice for vaccine development. PA has four different domains with different functions. In this study, the major domains of PA were cloned and expressed in bacterial system. The purified recombinant proteins were used to determine the humoral immune response by ELISA using 43 human cutaneous anthrax serum samples. The maximum immunoreactivity was observed with the whole PA protein followed by domain 2, 4 and 1. The study corroborated that in addition to full PA, individual domain 2 and 4 can also be good target for vaccine development as well as for serodiagnostic assays for cutaneous anthrax
Key Words Anthrax  Bacillus Anthracis  Domain  Vaccine  Protective Antigen 
        Export Export